Swedbank Ab Biogen Inc. Transaction History

Swedbank Ab

$79.2 Billion
Q4 2024

A detailed history of Swedbank Ab transactions in Biogen Inc. stock. As of the latest transaction made, Swedbank Ab holds 184,045 shares of BIIB stock, worth $26.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

184,045

Holding current value

$26.9 Million

% of portfolio

0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$146.47 - $191.55 $27 Million - $35.3 Million	184,045 New	184,045 $28.1 Million
Q3 2024 Oct 15, 2024	BUY	$189.07 - $236.8 $16.1 Million - $20.1 Million	84,981 Added 84.96%	185,008 $35.9 Million
Q2 2024 Jul 18, 2024	SELL	$190.52 - $236.72 $1.21 Million - $1.5 Million	-6,356 Reduced 5.97%	100,027 $23.2 Million
Q1 2024 May 21, 2024	BUY	$212.02 - $267.71 $22.6 Million - $28.5 Million	106,383 New	106,383 $22.9 Billion
Q4 2023 Dec 09, 2024	SELL	$222.59 - $267.94 $1.22 Million - $1.47 Million	-5,498 Reduced 4.92%	106,156 $27.5 Million
Q3 2023 Dec 09, 2024	SELL	$253.3 - $285.89 $3.26 Million - $3.68 Million	-12,878 Reduced 10.34%	111,654 $28.7 Million
Q2 2023 Dec 09, 2024	SELL	$275.25 - $318.06 $163,773 - $189,245	-595 Reduced 0.48%	124,532 $35.5 Million
Q1 2023 Dec 09, 2024	BUY	$256.56 - $292.34 $801,750 - $913,562	3,125 Added 2.56%	125,127 $34.8 Million
Q4 2022 Dec 09, 2024	SELL	$252.44 - $306.72 $3.55 Million - $4.31 Million	-14,068 Reduced 10.34%	122,002 $33.8 Million
Q3 2022 Dec 09, 2024	SELL	$194.69 - $268.46 $989,998 - $1.37 Million	-5,085 Reduced 3.6%	136,070 $36.3 Million
Q2 2022 Dec 09, 2024	SELL	$187.54 - $223.02 $7.68 Million - $9.14 Million	-40,974 Reduced 22.5%	141,155 $28.8 Million
Q1 2022 Dec 09, 2024	SELL	$193.77 - $244.14 $1.62 Million - $2.04 Million	-8,347 Reduced 4.38%	182,129 $38.4 Million
Q4 2021 Dec 09, 2024	SELL	$223.92 - $287.77 $4.57 Million - $5.87 Million	-20,388 Reduced 9.67%	190,476 $45.7 Million
Q3 2021 Dec 09, 2024	BUY	$282.99 - $369.05 $731,246 - $953,625	2,584 Added 1.24%	210,864 $59.7 Million
Q2 2021 Dec 09, 2024	SELL	$259.0 - $414.71 $8.42 Million - $13.5 Million	-32,512 Reduced 13.5%	208,280 $72.1 Million
Q1 2021 Dec 09, 2024	BUY	$242.95 - $284.63 $58.5 Million - $68.5 Million	240,792 New	240,792 $67.4 Million

Others Institutions Holding BIIB

# of Institutions

1,006

Shares Held

129M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Account